Lonny Yarmus, DO
Pulmonary Disease · Baltimore, MDNPI 1548367790
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Veran Medical Technologies, Inc. at 30.1% of the total. Reporting peaked in 2019 at $238,246 and has fallen 91.4% since, to $20,405 in 2025. Among pulmonary disease clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 547 payments — averaging $1063.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veran Medical Technologies, Inc.$175K
- AstraZeneca$149K
- Olympus Corporation Of The Americas$39K
- Intuitive Surgical$29K
- Isoray, Inc$24K
- Olympus America Inc.$23K
- plus $143K from 24 others
Across 19 payments — averaging $31,815 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Veran Medical Technologies, Inc.$262K
- AstraZeneca$146K
- Erbe Elektromedizin GmbH$144K
- Fujifilm Healthcare Americas Corporation$36K
- United Therapeutics Corporation$17K
Across 1 payment — averaging $18,882 each. An ownership or investment interest held by the physician or an immediate family member.
- Pleural Dynamics Inc.$19K
What the payments were for
- Consulting fees$309,67153%
- Speaking & faculty fees$141,63924%
- Travel & lodging$85,40215%
- Food & beverage$20,0093%
- Education$25,0804%
- Gifts$930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veran Medical Technologies, Inc. | 78 | $174,959 |
| AstraZeneca | 165 | $149,136 |
| Olympus Corporation Of The Americas | 57 | $39,150 |
| Intuitive Surgical | 66 | $28,940 |
| Isoray, Inc | 6 | $24,309 |
| Olympus America Inc. | 34 | $22,627 |
| Erbe Elektromedizin GmbH | 5 | $18,528 |
| Elucent Medical | 5 | $16,075 |
| ERBE USA Inc | 18 | $15,022 |
| Astrazeneca UK Limited | 10 | $13,574 |
| Boston Scientific | 12 | $13,245 |
| Eli Lilly | 28 | $12,473 |
| Ambu A/s | 2 | $11,570 |
| Pleural Dynamics Inc. | 5 | $8,475 |
| Fujifilm Healthcare Americas Corporation | 9 | $6,982 |
| Olympus Medical Systems Corporation | 5 | $6,525 |
| Olympus Corporation | 6 | $5,223 |
| Johnson & Johnson | 6 | $4,897 |
| Pinnacle Biologics, Inc | 10 | $4,591 |
| Olympus Winter & Ibe GmbH | 3 | $2,200 |
| Spiration, Inc. | 2 | $1,760 |
| Ambu Inc. | 5 | $388 |
| Merit Medical Systems Inc | 1 | $350 |
| Medtronic | 2 | $257 |
| Coaptech, Inc. | 1 | $250 |
| Auris Health, Inc. | 1 | $144 |
| Fisher & Paykel Healthcare Inc | 1 | $91 |
| Steris Corporation | 1 | $89 |
| Getinge USA Sales, LLC | 1 | $55 |
| Pulmonx Corporation | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spin$166,895
- IMFINZI$133,893
- Da Vinci Surgical System$27,622
- SINGLE USE SUCTION VALVE (Sterile)$25,978
- Brachytherapy Source$24,246
- Single Use Aspiration Needle$21,142
- Olympus Bronchoscopes$15,279
- TAGRISSO$11,824
- Erbe VIO$10,991
- Single Use Guide Sheath Kit$9,774
- Automatic Continuous Effusion Shunt (ACES) System$8,382
- GENERAL PULMONARY$6,838
- GENERAL BRONCHIAL THERMOPLASTY$5,760
- SPiN Thoracic Navigation System, 120V, 60Hz$5,173
- FUJIFILM$4,855
- Photofrin$4,464
- Olympus$4,180
- Monarch Platform$4,047
- EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE$3,520
- OES BRONCHOFIBERSCOPE$2,200
How this compares
$581,894 in reported general payments places this provider in the 95th percentile of 297 pulmonary disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Baltimore
- Alan SchwartzBaltimore$1.3M
- Hitesh BatraBaltimore$611K
- Robert WiseBaltimore$389K
- Ko Pen WangBaltimore$280K
- Hans LeeBaltimore$277K
- Angela ArgentoBaltimore$269K
- Michael DrummondBaltimore$263K
- Jason AkulianBaltimore$231K
- Kathryn RobinettBaltimore$160K
- Sonye DanoffBaltimore$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.